Skip to search formSkip to main contentSkip to account menu

antagonists & inhibitors

Known as: inhibitor/antagonist 
Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism.
National Institutes of Health

Related topics

Related topics

50 relations
1-Methyl-4-phenylpyridiniumAcetate KinaseAdaptor Protein Complex 2Arylsulfatases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
An update on evidence for mineralocorticoid receptor antagonist in the treatment of central serous retinopathy
As most patients of central serous retinopathy (CSC), the symptoms of acute onset will alleviate by oneself after 4-6 months… 
2014
2014
Lipsanen Secondary Neuropathology after Experimental Stroke With Special Emphasis on Calcium , Amyloid-β and Inflammation
  • Anu
  • 2014
  • Corpus ID: 43922814
One out of every three people will suffer either a stroke or develop Alzheimer’s disease (AD). In a world with continuous… 
2014
2014
Secondary Neuropathology after Experimental Stroke With Special Emphasis on Calcium , Amyloid-β and Inflammation
One out of every three people will suffer either a stroke or develop Alzheimer’s disease (AD). In a world with continuous… 
Review
2006
Review
2006
Biochemical Mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001‐2004: Mechanisms leading to optimal efficacy and safety.
The United States FDA approved 85 New Molecular Entities (NMEs) during the period from January 2001 to November 2004 of which 61… 
2006
2006
Enhancement of HSV-TK / GCV suicide gene therapy of cancer
Gene therapy has become a promising alternative treatment form for cancer. Among the broad range of different genetic means to… 
Highly Cited
2003
Highly Cited
2003
Effects of angiotensin-(1-7) and other bioactive components of the renin–angiotensin system on vascular resistance and noradrenaline release in rat kidney
Objective Angiotensin (Ang) is broken down enzymatically to several different metabolites which, in addition to Ang II, may have… 
1997
1997
Modulation of endotoxin-induced inflammation in the bovine teat using antagonists/inhibitors to leukotrienes, platelet activating factor and interleukin 1 beta.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)